{"filing":{"accession_number":"0002046386-26-000049","cik":"0002046386","ticker":"MDLN","company_name":"Medline Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"mdln-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000049/mdln-20260805.htm"},"events":[{"id":25305,"run_id":22962,"accession_number":"0002046386-26-000049","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Medline Inc. issued an earnings press release on August 5, 2026, announcing second quarter and first six months 2026 financial results, including net sales of $7.7 billion (Q2) and $15.0 billion (H1), net income figures, Adjusted EBITDA, and updated full-year 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02, furnished as Exhibit 99.1, and is material to investors assessing the company's financial performance and operational trajectory.","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":26093,"accession_number":"0002046386-26-000049","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Medline Inc. issued an earnings press release on August 5, 2026, announcing second quarter and first six months 2026 financial results, including net sales of $7.7 billion (Q2) and $15.0 billion (H1), net income figures, Adjusted EBITDA, and updated full-year 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02, furnished as Exhibit 99.1, and is material to investors assessing the company's financial performance and operational trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:30:29.135624+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26093,"accession_number":"0002046386-26-000049","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Medline Inc. issued an earnings press release on August 5, 2026, announcing second quarter and first six months 2026 financial results, including net sales of $7.7 billion (Q2) and $15.0 billion (H1), net income figures, Adjusted EBITDA, and updated full-year 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02, furnished as Exhibit 99.1, and is material to investors assessing the company's financial performance and operational trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:30:29.135624+00:00","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-08-05"}]}